Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

1.

ALDH-1 expression levels predict response or resistance to preoperative chemoradiation in resectable esophageal cancer patients.

Ajani JA, Wang X, Song S, Suzuki A, Taketa T, Sudo K, Wadhwa R, Hofstetter WL, Komaki R, Maru DM, Lee JH, Bhutani MS, Weston B, Baladandayuthapani V, Yao Y, Honjo S, Scott AW, Skinner HD, Johnson RL, Berry D.

Mol Oncol. 2014 Feb;8(1):142-9. doi: 10.1016/j.molonc.2013.10.007. Epub 2013 Oct 28.

PMID:
24210755
[PubMed - indexed for MEDLINE]
2.

Gene expression profiling of localized esophageal carcinomas: association with pathologic response to preoperative chemoradiation.

Luthra R, Wu TT, Luthra MG, Izzo J, Lopez-Alvarez E, Zhang L, Bailey J, Lee JH, Bresalier R, Rashid A, Swisher SG, Ajani JA.

J Clin Oncol. 2006 Jan 10;24(2):259-67. Epub 2005 Dec 12.

PMID:
16344314
[PubMed - indexed for MEDLINE]
Free Article
3.

Loss of Bcl-2 expression in Barrett's dysplasia and adenocarcinoma is associated with tumor progression and worse survival but not with response to neoadjuvant chemoradiation.

Raouf AA, Evoy DA, Carton E, Mulligan E, Griffin MM, Reynolds JV.

Dis Esophagus. 2003;16(1):17-23.

PMID:
12581249
[PubMed - indexed for MEDLINE]
4.

A validated miRNA profile predicts response to therapy in esophageal adenocarcinoma.

Skinner HD, Lee JH, Bhutani MS, Weston B, Hofstetter W, Komaki R, Shiozaki H, Wadhwa R, Sudo K, Elimova E, Song S, Ye Y, Huang M, Ajani J, Wu X.

Cancer. 2014 Dec 1;120(23):3635-41. doi: 10.1002/cncr.28911. Epub 2014 Aug 4.

PMID:
25091571
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Prognostic significance of vascular endothelial growth factor and cyclooxygenase 2 expression in patients receiving preoperative chemoradiation for esophageal cancer.

Kulke MH, Odze RD, Mueller JD, Wang H, Redston M, Bertagnolli MM.

J Thorac Cardiovasc Surg. 2004 Jun;127(6):1579-86.

PMID:
15173710
[PubMed - indexed for MEDLINE]
6.

Characterization of pathologic complete response after preoperative chemoradiotherapy in carcinoma of the esophagus and outcome after pathologic complete response.

Rohatgi P, Swisher SG, Correa AM, Wu TT, Liao Z, Komaki R, Walsh GL, Vaporciyan AA, Rice DC, Roth JA, Ajani JA.

Cancer. 2005 Dec 1;104(11):2365-72.

PMID:
16245310
[PubMed - indexed for MEDLINE]
Free Article
7.

Downregulation of TS, DPD, ERCC1, GST-Pi, EGFR, and HER2 gene expression after neoadjuvant three-modality treatment in patients with esophageal cancer.

Schneider S, Uchida K, Brabender J, Baldus SE, Yochim J, Danenberg KD, Salonga D, Chen P, Tsao-Wei D, Groshen S, Hoelscher AH, Schneider PM, Danenberg PV.

J Am Coll Surg. 2005 Mar;200(3):336-44.

PMID:
15737843
[PubMed - indexed for MEDLINE]
8.

Phosphorylated mammalian target of rapamycin expression is associated with the response to chemoradiotherapy in patients with esophageal squamous cell carcinoma.

Li SH, Huang EY, Lu HI, Huang WT, Yen CC, Huang WC, Chen CH.

J Thorac Cardiovasc Surg. 2012 Dec;144(6):1352-9, 1359.e1. doi: 10.1016/j.jtcvs.2012.06.049. Epub 2012 Jul 25.

PMID:
22841170
[PubMed - indexed for MEDLINE]
9.

Tumour expression of leptin is associated with chemotherapy resistance and therapy-independent prognosis in gastro-oesophageal adenocarcinomas.

Bain GH, Collie-Duguid E, Murray GI, Gilbert FJ, Denison A, McKiddie F, Ahearn T, Fleming I, Leeds J, Phull P, Park K, Nanthakumaran S, Grabsch HI, Tan P, Welch A, Schweiger L, Dahle-Smith A, Urquhart G, Finegan M, Petty RD.

Br J Cancer. 2014 Mar 18;110(6):1525-34. doi: 10.1038/bjc.2014.45. Epub 2014 Feb 25.

PMID:
24569475
[PubMed - indexed for MEDLINE]
10.

Signet ring cells in esophageal adenocarcinoma predict poor response to preoperative chemoradiation.

Patel VR, Hofstetter WL, Correa AM, Agarwal A, Rashid A, Bhutani MS, Lin SH, Ajani JA, Swisher SG, Maru DM.

Ann Thorac Surg. 2014 Sep;98(3):1064-71. doi: 10.1016/j.athoracsur.2014.04.099. Epub 2014 Jul 16.

PMID:
25038008
[PubMed - indexed for MEDLINE]
11.

Trimodality therapy without a platinum compound for localized carcinoma of the esophagus and gastroesophageal junction.

Ajani JA, Correa AM, Walsh GL, Komaki R, Lee JH, Vaporciyan AA, Rice DC, Yao JC, Maru DM, Hofstetter WL, Phan AT, Swisher SG.

Cancer. 2010 Apr 1;116(7):1656-63. doi: 10.1002/cncr.24935.

PMID:
20143431
[PubMed - indexed for MEDLINE]
Free Article
12.

Neoadjuvant chemotherapy or chemoradiotherapy for locally advanced esophageal cancer.

Smithers BM, Thomson I.

Thorac Surg Clin. 2013 Nov;23(4):509-23. doi: 10.1016/j.thorsurg.2013.07.005. Epub 2013 Oct 13. Review.

PMID:
24199701
[PubMed - indexed for MEDLINE]
13.

ALDH activity selectively defines an enhanced tumor-initiating cell population relative to CD133 expression in human pancreatic adenocarcinoma.

Kim MP, Fleming JB, Wang H, Abbruzzese JL, Choi W, Kopetz S, McConkey DJ, Evans DB, Gallick GE.

PLoS One. 2011;6(6):e20636. doi: 10.1371/journal.pone.0020636. Epub 2011 Jun 13.

PMID:
21695188
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Neoadjuvant radiochemotherapy in adenocarcinoma of the esophagus: ERCC1 gene polymorphisms for prediction of response and prognosis.

Metzger R, Warnecke-Eberz U, Alakus H, Kütting F, Brabender J, Vallböhmer D, Grimminger PP, Mönig SP, Drebber U, Hölscher AH, Bollschweiler E.

J Gastrointest Surg. 2012 Jan;16(1):26-34; discussion 34. doi: 10.1007/s11605-011-1700-x. Epub 2011 Sep 29.

PMID:
21956434
[PubMed - indexed for MEDLINE]
15.

Results of the baseline positron emission tomography can customize therapy of localized esophageal adenocarcinoma patients who achieve a clinical complete response after chemoradiation.

Suzuki A, Xiao L, Taketa T, Sudo K, Wadhwa R, Blum MA, Skinner H, Komaki R, Weston B, Lee JH, Bhutani MS, Rice DC, Maru DM, Erasmus J, Swisher SG, Hofstetter WL, Ajani JA.

Ann Oncol. 2013 Nov;24(11):2854-9. doi: 10.1093/annonc/mdt340. Epub 2013 Aug 29.

PMID:
23994746
[PubMed - indexed for MEDLINE]
Free Article
16.

High gene expression of TS1, GSTP1, and ERCC1 are risk factors for survival in patients treated with trimodality therapy for esophageal cancer.

Joshi MB, Shirota Y, Danenberg KD, Conlon DH, Salonga DS, Herndon JE 2nd, Danenberg PV, Harpole DH Jr.

Clin Cancer Res. 2005 Mar 15;11(6):2215-21.

PMID:
15788669
[PubMed - indexed for MEDLINE]
Free Article
17.

Influence of the baseline 18F-fluoro-2-deoxy-D-glucose positron emission tomography results on survival and pathologic response in patients with gastroesophageal cancer undergoing chemoradiation.

Javeri H, Xiao L, Rohren E, Komaki R, Hofstetter W, Lee JH, Maru D, Bhutani MS, Swisher SG, Wang X, Ajani JA.

Cancer. 2009 Feb 1;115(3):624-30. doi: 10.1002/cncr.24056.

PMID:
19130466
[PubMed - indexed for MEDLINE]
Free Article
18.

A nomogram associated with high probability of malignant nodes in the surgical specimen after trimodality therapy of patients with oesophageal cancer.

Hayashi Y, Xiao L, Suzuki A, Blum MA, Sabloff B, Taketa T, Maru DM, Welsh J, Lin SH, Weston B, Lee JH, Bhutani MS, Hofstetter WL, Swisher SG, Ajani JA.

Eur J Cancer. 2012 Dec;48(18):3396-404. doi: 10.1016/j.ejca.2012.06.020. Epub 2012 Jul 31.

PMID:
22853875
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Association of pretherapeutic expression of chemotherapy-related genes with response to neoadjuvant chemotherapy in Barrett carcinoma.

Langer R, Specht K, Becker K, Ewald P, Bekesch M, Sarbia M, Busch R, Feith M, Stein HJ, Siewert JR, Höfler H.

Clin Cancer Res. 2005 Oct 15;11(20):7462-9.

PMID:
16243820
[PubMed - indexed for MEDLINE]
Free Article
20.

The significance of neuroendocrine differentiation in adenocarcinoma of the esophagus and esophagogastric junction after preoperative chemoradiation.

Wang KL, Yang Q, Cleary KR, Swisher SG, Correa AM, Komaki R, Ajani JA, Rashid A, Hamilton SR, Wu TT.

Cancer. 2006 Oct 1;107(7):1467-74.

PMID:
16955509
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk